治療診斷學市場規模、佔有率和趨勢分析報告：按放射性同位素、方法、應用、地區和細分市場預測，2026-2033年

Radiotheranostics Market Size, Share & Trends Analysis Report By Radioisotope, By Approach, By Application, By Region, And Segment Forecasts, 2026 - 2033

出版日期: 2026年01月15日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

治療診斷學市場概述

2025年全球治療診斷學市場規模估計為117.9億美元，預計2033年將達到255.6億美元。

預計從 2026 年到 2033 年，該市場將以 9.5% 的複合年成長率成長。該市場代表了一種精準醫療方法，它將分子影像和標靶放射性核素治療相結合，以改善患者選擇、治療準確性和長期療效監測。

透過圍繞同一生物標的整合診斷和治療，治療診斷學能夠降低臨床不確定性，支持個人化給藥策略，並實現先進腫瘤資源的有效利用。例如，2025年3月，Actinium Pharmaceuticals公司宣布其治療診斷學產品線取得進展，強調了標靶放射性藥物療法的持續研發。這反映了整個產業向經臨床檢驗的、以標靶驅動的治療平台發展的趨勢。不斷擴大的臨床證據、監管機構對靶向放射性藥物日益成長的認可，以及專科腫瘤和核醫學中心的廣泛應用，都為市場接受度的提升提供了支持。然而，同位素供應、生產擴充性、基礎設施準備以及醫保報銷等方面的限制因素正在限制該領域的進展。整個生態系統的策略重點包括靶向配體創新、建立長期的同位素供應夥伴關係，以及確保臨床環境一致性和合規性的服務交付模式。

目前治療診斷學市場正經歷臨床應用範圍的穩定擴展和操作複雜性的不斷提高。該治療方法正從早期應用階段走向更有系統地整合到癌症治療路徑中。研發活動主要集中在提高標靶化精準度、最佳化放射性核種以及整合先進的影像和劑量測定工具以支援個人化治療方案的發展。創新不僅限於已有的基於胜肽的放射性配體；抗體片段、設計胜肽和小分子載體方面的投資也在增加，這些技術能夠提高腫瘤特異性和治療指數。同時，α發射體計畫的進展正在塑造下一代產品線，以應對抗藥性和轉移性疾病的挑戰。

儘管取得了這些進展，但市場擴張仍然受到許多實際因素的限制，包括治療場所的同位素供應、生產擴充性、低溫運輸物流以及基礎設施建設。醫療系統正在探索樞紐輻射式供應模式，並與外部放射性藥物分發部門合作，以應對複雜性並確保藥物的可及性。報銷政策的一致性仍然是支付方評估診斷和治療領域臨床價值的關鍵因素。例如，SHINE Technologies 於 2024 年 10 月宣布的一項合作臨床前研究（公司新聞稿）顯示，一種新型放射性治療診斷候選藥物在前列腺癌和腎癌模型中展現出令人鼓舞的腫瘤消退效果，這支持了同位素生產和靶向放射性藥物開發交叉領域的持續創新。

2025年及2033年區域市佔率分析
區域市場概覽
市場規模及預測趨勢分析，2021-2033年
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 丹麥
- 挪威
- 瑞典
亞太地區
- 日本
- 中國
- 印度
- 韓國
- 澳洲
- 泰國
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

第8章競爭情勢

參與公司概況
企業市場分析
公司分類
策略規劃
公司簡介/列表
- Bayer
- Lantheus Holdings
- POINT Biopharma
- Telix Pharmaceuticals
- Actinium Pharmaceuticals
- RadioMedix
- IsoRay
- SHINE Technologies
- NorthStar Medical Radioisotopes
- Fusion Pharmaceuticals
- Novartis

簡介目錄圖表

Product Code: GVR-4-68040-066-7

Radiotheranostics Market Summary

The global radiotheranostics market size was estimated at USD 11.79 billion in 2025 and is projected to reach USD 25.56 billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033. The market represents a precision medicine approach that integrates molecular imaging with targeted radionuclide therapy to enhance patient selection, treatment accuracy, and longitudinal outcome monitoring.

By unifying diagnostics and therapy around the same biological target, radiotheranostics reduces clinical uncertainty, supports individualized dosing strategies, and enables more efficient utilization of advanced oncology resources. For instance, in March 2025, according to Actinium Pharmaceuticals, the company announced progress in its radiotheranostic pipeline, underscoring continued development of targeted radiopharmaceutical therapies, reflecting broader industry momentum toward clinically validated, target-driven treatment platforms. Market adoption is supported by expanding clinical evidence, increasing regulatory acceptance of targeted radiopharmaceuticals, and growing uptake across specialized oncology and nuclear medicine centers, while progression is moderated by constraints related to isotope availability, manufacturing scalability, infrastructure readiness, and reimbursement alignment. Strategic priorities across the ecosystem include innovation in targeting ligands, long-term isotope supply partnerships, and service delivery models that ensure consistent and compliant clinical deployment across care settings.

The current radiotheranostics market scenario is characterized by steady clinical expansion and increasing operational sophistication, as the modality moves from early adoption toward more structured integration within oncology care pathways. Development activity is increasingly focused on improving targeting accuracy, optimizing radionuclide selection, and embedding advanced imaging and dosimetry tools to support personalized treatment planning. Innovation is no longer limited to established peptide based radioligands, with growing investment in antibody fragments, engineered peptides, and small molecule vectors that enhance tumor specificity and therapeutic index. Parallel advances in alpha emitter programs are shaping next generation pipelines aimed at addressing resistant and metastatic disease settings.

Despite this momentum, market progression continues to be moderated by practical constraints related to isotope availability, manufacturing scalability, cold chain logistics, and infrastructure readiness across treatment centers. Health systems are evaluating hub and spoke delivery models and external radiopharmacy partnerships to manage complexity while preserving access. Reimbursement alignment remains a critical factor, as payers assess clinical value across both diagnostic and therapeutic components. For instance, in October 2024, according to SHINE Technologies (company press release), collaborative preclinical research demonstrated promising tumor regression outcomes for novel radiotheranostic candidates in prostate and kidney cancer models, underscoring sustained innovation at the intersection of isotope production and targeted radiopharmaceutical development.

Global Radiotheranostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global radiotheranostics market report based on radioisotope, approach, application, and region:

Radioisotope Outlook (Revenue, USD Million, 2021 - 2033)
Iodine-131
Iodine-123
Gallium-68
Lutetium-177
18F with Y-90
Others
Approach Outlook (Revenue, USD Million, 2021 - 2033)
Targeted Therapeutic
Targeted Diagnostic
Application Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
- Thyroid Cancer
- Neuroendocrine Tumor
- Hepatocellular Carcinoma
- Prostate Cancer
- Others
Non-Oncology
- Neurological Disorders
- Arthritis
- Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1 Market Segmentation & Scope
1.2 Segment Definitions
- 1.2.1 Radioisotope
- 1.2.2 Approach
- 1.2.3 Application
1.3 Estimates and Forecast Timeline
1.4 Research Methodology
1.5 Information Procurement
- 1.5.1 Purchased Database
- 1.5.2 GVR's Internal Database
- 1.5.3 Secondary Sources
- 1.5.4 Primary Research
1.6 Information Analysis
- 1.6.1 Data Analysis Models
1.7 Market Formulation & Data Visualization
1.8 Model Details
- 1.8.1 Commodity Flow Analysis
1.9 List of Secondary Sources
1.10 Objectives

Chapter 2. Executive Summary

2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot

Chapter 3 Radiotheranostics Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
3.3 Business Environment Analysis
- 3.3.1 Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1 Supplier Power
  - 3.3.1.2 Buyer Power
  - 3.3.1.3 Substitution Threat
  - 3.3.1.4 Threat of New Entrants
  - 3.3.1.5 Competitive Rivalry
- 3.3.2 PESTLE Analysis
- 3.3.3 Pipeline Analysis
- 3.3.4 Patent Expiry Analysis
- 3.3.5 Pricing Analysis

Chapter 4. Radiotheranostics Market: Radioisotope Business Analysis

4.1. Radioisotope Market Share, 2025 & 2033
4.2. Radioisotope Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Radioisotope, 2021 to 2033 (USD Million)
4.4. Iodine-131
- 4.4.1 Iodine-131 Market, 2021 - 2033 (USD Million)
4.5. Iodine-123
- 4.5.1 Iodine-123 Market, 2021 - 2033 (USD Million)
4.6. Gallium-68
- 4.6.1 Gallium-68 Market, 2021 - 2033 (USD Million)
4.7. Lutetium-177
- 4.7.1 Lutetium-177 Market, 2021 - 2033 (USD Million)
4.8. 18F with Y-90
- 4.8.1 18F with Y-90 Market, 2021 - 2033 (USD Million)
4.9. Others
- 4.9.1 Others Market, 2021 - 2033 (USD Million)

Chapter 5. Radiotheranostics Market: Approach Business Analysis

5.1. Approach Market Share, 2025 & 2033
5.2. Approach Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Approach, 2021 to 2033 (USD Million)
5.4. Targeted Therapeutic
- 5.4.1 Targeted Therapeutic Market, 2021 - 2033 (USD Million)
5.5. Targeted Diagnostic
- 5.5.1 Targeted Diagnostic Market, 2021 - 2033 (USD Million)

Chapter 6. Radiotheranostics Market: Application Business Analysis

6.1. Application Market Share, 2025 & 2033
6.2. Application Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Oncology
- 6.4.1 Oncology Market, 2021 - 2033 (USD Million)
  - 6.4.1.1 Thyroid Cancer Market, 2021 - 2033 (USD Million)
  - 6.4.1.2 Neuroendocrine Tumor Market, 2021 - 2033 (USD Million)
  - 6.4.1.3 Hepatocellular Carcinoma Market, 2021 - 2033 (USD Million)
  - 6.4.1.4 Prostate Cancer Market, 2021 - 2033 (USD Million)
  - 6.4.1.5 Others Market, 2021 - 2033 (USD Million)
6.5. Non-Oncology
- 6.5.1 Non-Oncology Market, 2021 - 2033 (USD Million)
  - 6.5.1.1 Neurological Disorders Market, 2021 - 2033 (USD Million)
  - 6.5.1.2 Arthritis Market, 2021 - 2033 (USD Million)
  - 6.5.1.3 Others Market, 2021 - 2033 (USD Million)

Chapter 7. Radiotheranostics Market: Regional Estimates & Trend Analysis

7.1 Regional Market Share Analysis, 2025 & 2033
7.2 Regional Market Dashboard
7.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4 North America
- 7.4.1 North America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
- 7.4.2 U.S.
  - 7.4.2.1 Key Country Dynamics
  - 7.4.2.2 Regulatory Framework
  - 7.4.2.3 Reimbursement Scenario
  - 7.4.2.4 U.S. Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.4.3 Canada
  - 7.4.3.1 Key Country Dynamics
  - 7.4.3.2 Regulatory Framework
  - 7.4.3.3 Reimbursement Scenario
  - 7.4.3.4 Canada Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.4.4 Mexico
  - 7.4.4.1 Key Country Dynamics
  - 7.4.4.2 Regulatory Framework
  - 7.4.4.3 Reimbursement Scenario
  - 7.4.4.4 Mexico Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5 Europe
- 7.5.1 Europe Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
- 7.5.2 UK
  - 7.5.2.1 Key Country Dynamics
  - 7.5.2.2 Regulatory Framework
  - 7.5.2.3 Reimbursement Scenario
  - 7.5.2.4 UK Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.3 Germany
  - 7.5.3.1 Key Country Dynamics
  - 7.5.3.2 Regulatory Framework
  - 7.5.3.3 Reimbursement Scenario
  - 7.5.3.4 Germany Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.4 France
  - 7.5.4.1 Key Country Dynamics
  - 7.5.4.2 Regulatory Framework
  - 7.5.4.3 Reimbursement Scenario
  - 7.5.4.4 France Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.5 Italy
  - 7.5.5.1 Key Country Dynamics
  - 7.5.5.2 Regulatory Framework
  - 7.5.5.3 Reimbursement Scenario
  - 7.5.5.4 Italy Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.6 Spain
  - 7.5.6.1 Key Country Dynamics
  - 7.5.6.2 Regulatory Framework
  - 7.5.6.3 Reimbursement Scenario
  - 7.5.6.4 Spain Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.7 Denmark
  - 7.5.7.1 Key Country Dynamics
  - 7.5.7.2 Regulatory Framework
  - 7.5.7.3 Reimbursement Scenario
  - 7.5.7.4 Denmark Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.8 Norway
  - 7.5.8.1 Key Country Dynamics
  - 7.5.8.2 Regulatory Framework
  - 7.5.8.3 Reimbursement Scenario
  - 7.5.8.4 Norway Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.5.9 Sweden
  - 7.5.7.1 Key Country Dynamics
  - 7.5.7.2 Regulatory Framework
  - 7.5.7.3 Reimbursement Scenario
  - 7.5.7.4 Sweden Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6 Asia Pacific
- 7.6.1 Asia Pacific Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
- 7.6.2 Japan
  - 7.6.2.1 Key Country Dynamics
  - 7.6.2.2 Regulatory Framework
  - 7.6.2.3 Reimbursement Scenario
  - 7.6.2.4 Japan Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.6.3 China
  - 7.6.3.1 Key Country Dynamics
  - 7.6.3.2 Regulatory Framework
  - 7.6.3.3 Reimbursement Scenario
  - 7.6.3.4 China Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.6.4 India
  - 7.6.4.1 Key Country Dynamics
  - 7.6.4.2 Regulatory Framework
  - 7.6.4.3 Reimbursement Scenario
  - 7.6.4.4 India Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.6.5 South Korea
  - 7.6.5.1 Key Country Dynamics
  - 7.6.5.2 Regulatory Framework
  - 7.6.5.3 Reimbursement Scenario
  - 7.6.5.4 South Korea Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.6.6 Australia
  - 7.6.6.1 Key Country Dynamics
  - 7.6.6.2 Regulatory Framework
  - 7.6.6.3 Reimbursement Scenario
  - 7.6.6.4 Australia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.6.7 Thailand
  - 7.6.7.1 Key Country Dynamics
  - 7.6.7.2 Regulatory Framework
  - 7.6.7.3 Reimbursement Scenario
  - 7.6.7.4 Thailand Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7 Latin America
- 7.7.1 Latin America Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
- 7.7.2 Brazil
  - 7.7.2.1 Key Country Dynamics
  - 7.7.2.2 Regulatory Framework
  - 7.7.2.3 Reimbursement Scenario
  - 7.7.2.4 Brazil Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.7.3 Argentina
  - 7.7.3.1 Key Country Dynamics
  - 7.7.3.2 Regulatory Framework
  - 7.7.3.3 Reimbursement Scenario
  - 7.7.3.4 Argentina Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8 Middle East & Africa
- 7.8.1 Middle East & Africa Radiotheranostics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
- 7.8.2 South Africa
  - 7.8.2.1 Key Country Dynamics
  - 7.8.2.2 Regulatory Framework
  - 7.8.2.3 Reimbursement Scenario
  - 7.8.2.4 South Africa Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.8.3 Saudi Arabia
  - 7.8.3.1 Key Country Dynamics
  - 7.8.3.2 Regulatory Framework
  - 7.8.3.3 Reimbursement Scenario
  - 7.8.3.4 Saudi Arabia Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.8.4 UAE
  - 7.8.4.1 Key Country Dynamics
  - 7.8.4.2 Regulatory Framework
  - 7.8.4.3 Reimbursement Scenario
  - 7.8.4.4 UAE Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)
- 7.8.5 Kuwait
  - 7.8.5.1 Key Country Dynamics
  - 7.8.5.2 Regulatory Framework
  - 7.8.5.3 Reimbursement Scenario
  - 7.8.5.4 Kuwait Radiotheranostics Market Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1 Bayer
  - 8.5.1.1 Overview
  - 8.5.1.2 Financial Performance
  - 8.5.1.3 Product Benchmarking
  - 8.5.1.4 Strategic Initiatives
- 8.5.2 Lantheus Holdings
  - 8.5.2.1 Overview
  - 8.5.2.2 Financial Performance
  - 8.5.2.3 Product Benchmarking
  - 8.5.2.4 Strategic Initiatives
- 8.5.3 POINT Biopharma
  - 8.5.3.1 Overview
  - 8.5.3.2 Financial Performance
  - 8.5.3.3 Product Benchmarking
  - 8.5.3.4 Strategic Initiatives
- 8.5.4 Telix Pharmaceuticals
  - 8.5.4.1 Overview
  - 8.5.4.2 Financial Performance
  - 8.5.4.3 Product Benchmarking
  - 8.5.4.4 Strategic Initiatives
- 8.5.5 Actinium Pharmaceuticals
  - 8.5.5.1 Overview
  - 8.5.5.2 Financial Performance
  - 8.5.5.3 Product Benchmarking
  - 8.5.5.4 Strategic Initiatives
- 8.5.6 RadioMedix
  - 8.5.6.1 Overview
  - 8.5.6.2 Financial Performance
  - 8.5.6.3 Product Benchmarking
  - 8.5.6.4 Strategic Initiatives
- 8.5.7 IsoRay
  - 8.5.7.1 Overview
  - 8.5.7.2 Financial Performance
  - 8.5.7.3 Product Benchmarking
  - 8.5.7.4 Strategic Initiatives
- 8.5.8 SHINE Technologies
  - 8.5.8.1 Overview
  - 8.5.8.2 Financial Performance
  - 8.5.8.3 Product Benchmarking
  - 8.5.8.4 Strategic Initiatives
- 8.5.9 NorthStar Medical Radioisotopes
  - 8.5.9.1 Overview
  - 8.5.9.2 Financial Performance
  - 8.5.9.3 Product Benchmarking
  - 8.5.9.4 Strategic Initiatives
- 8.5.10 Fusion Pharmaceuticals
  - 8.5.10.1 Overview
  - 8.5.10.2 Financial Performance
  - 8.5.10.3 Product Benchmarking
  - 8.5.10.4 Strategic Initiatives
- 8.5.11 Novartis
  - 8.5.11.1 Overview
  - 8.5.11.2 Financial Performance
  - 8.5.11.3 Product Benchmarking
  - 8.5.11.4 Strategic Initiatives

簡介目錄圖表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Radiotheranostics Market Market, by Region, 2021 - 2033 (USD Million)
Table 4 Global Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 5 Global Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 6 Global Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 7 North America Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 8 North America Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 9 North America Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 10 North America Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 11 U.S. Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 12 U.S. Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 13 U.S. Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 14 Canada Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 15 Canada Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 16 Canada Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 17 Mexico Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 18 Mexico Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 19 Mexico Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 20 Europe Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 21 Europe Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 22 Europe Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 23 Europe Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 24 UK Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 25 UK Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 26 UK Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 27 Germany Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 28 Germany Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 29 Germany Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 30 France Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 31 France Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 32 France Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 33 Italy Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 34 Italy Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 35 Italy Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 36 Spain Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 37 Spain Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 38 Spain Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 39 Denmark Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 40 Denmark Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 41 Denmark Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 42 Norway Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 43 Norway Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 44 Norway Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 45 Sweden Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 46 Sweden Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 47 Sweden Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 48 Asia Pacific Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 49 Asia Pacific Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 50 Asia Pacific Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 51 Asia Pacific Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 52 Japan Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 53 Japan Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 54 Japan Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 55 China Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 56 China Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 57 China Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 58 India Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 59 India Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 60 India Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 61 South Korea Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 62 South Korea Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 63 South Korea Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 64 Australia Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 65 Australia Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 66 Australia Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 67 Thailand Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 68 Thailand Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 69 Thailand Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 70 Latin America Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 71 Latin America Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 72 Latin America Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 73 Latin America Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 74 Brazil Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 75 Brazil Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 76 Brazil Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 77 Argentina Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 78 Argentina Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 79 Argentina Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 80 Middle East & Africa Radiotheranostics Market Market, by Country, 2021 - 2033 (USD Million)
Table 81 Middle East & Africa Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 82 Middle East & Africa Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 83 Middle East & Africa Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 84 South Africa Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 85 South Africa Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 86 South Africa Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 89 Saudi Arabia Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 90 UAE Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 91 UAE Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 92 UAE Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)
Table 93 Kuwait Radiotheranostics Market Market, by Radioisotope, 2021 - 2033 (USD Million)
Table 94 Kuwait Radiotheranostics Market Market, by Approach, 2021 - 2033 (USD Million)
Table 95 Kuwait Radiotheranostics Market Market, by Application, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Radiotheranostics Market: market outlook
Fig. 14 Radiotheranostics Market: competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Radiotheranostics Market driver impact
Fig. 20 Radiotheranostics Market restraint impact
Fig. 21 Radiotheranostics Market strategic initiatives analysis
Fig. 22 Radiotheranostics Market: Radioisotope movement analysis
Fig. 23 Radiotheranostics Market: Radioisotope outlook and key takeaways
Fig. 24 Iodine-131 market estimates and forecast, 2021 - 2033
Fig. 25 Iodine-123 market estimates and forecast, 2021 - 2033
Fig. 26 Gallium-68 market estimates and forecast, 2021 - 2033
Fig. 27 Lutetium-177 market estimates and forecast, 2021 - 2033
Fig. 28 18F with Y-90 market estimates and forecast, 2021 - 2033
Fig. 29 Others market estimates and forecasts, 2021 - 2033
Fig. 30 Radiotheranostics Market: Approach movement analysis
Fig. 31 Radiotheranostics Market: Approach outlook and key takeaways
Fig. 32 Targeted Therapeutic market estimates and forecast, 2021 - 2033
Fig. 33 Targeted Diagnostic market estimates and forecast, 2021 - 2033
Fig. 34 Radiotheranostics Market: Application movement analysis
Fig. 35 Radiotheranostics Market: Application outlook and key takeaways
Fig. 36 Oncology market estimates and forecast, 2021 - 2033
Fig. 37 Thyroid Cancer market estimates and forecast, 2021 - 2033
Fig. 38 Neuroendocrine Tumor market estimates and forecast, 2021 - 2033
Fig. 39 Hepatocellular Carcinoma market estimates and forecast, 2021 - 2033
Fig. 40 Prostate Cancer market estimates and forecast, 2021 - 2033
Fig. 41 Others market estimates and forecasts, 2021 - 2033
Fig. 42 Non-Oncology market estimates and forecast, 2021 - 2033
Fig. 43 Neurological Disorders market estimates and forecast, 2021 - 2033
Fig. 44 Arthritis market estimates and forecast, 2021 - 2033
Fig. 45 Others market estimates and forecasts, 2021 - 2033
Fig. 46 Radiotheranostics Market: Regional movement analysis
Fig. 47 Radiotheranostics Market: Regional outlook and key takeaways
Fig. 48 Radiotheranostics Market share and leading players
Fig. 49 North America Radiotheranostics Market share and leading players
Fig. 50 Europe Radiotheranostics Market share and leading players
Fig. 51 Asia Pacific Radiotheranostics Market share and leading players
Fig. 52 Latin America Radiotheranostics Market share and leading players
Fig. 53 Middle East & Africa Radiotheranostics Market share and leading players
Fig. 54 North America Radiotheranostics Market SWOT Analysis
Fig. 55 Europe Radiotheranostics Market SWOT Analysis
Fig. 56 Asia Pacific Radiotheranostics Market SWOT Analysis
Fig. 57 Latin America Radiotheranostics Market SWOT Analysis
Fig. 58 Middle East & Africa Radiotheranostics Market SWOT Analysis
Fig. 59 North America Radiotheranostics Market Analysis, by country
Fig. 60 North America
Fig. 61 North America Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 62 U.S.
Fig. 63 U.S. Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 64 Canada
Fig. 65 Canada Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 66 Mexico
Fig. 67 Mexico Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 68 Europe
Fig. 69 Europe Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 70 UK
Fig. 71 UK Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 72 Germany
Fig. 73 Germany Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 74 France
Fig. 75 France Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 76 Italy
Fig. 77 Italy Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 78 Spain
Fig. 79 Spain Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 80 Denmark
Fig. 81 Denmark Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 82 Sweden
Fig. 83 Sweden Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 84 Norway
Fig. 85 Norway Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 86 Asia Pacific
Fig. 87 Asia Pacific Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 88 China
Fig. 89 China Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 90 Japan
Fig. 91 Japan Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 92 India
Fig. 93 India Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 94 Thailand
Fig. 95 Thailand Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 96 South Korea
Fig. 97 South Korea Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 98 Australia
Fig. 99 Australia Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 100 Latin America
Fig. 101 Latin America Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 102 Brazil
Fig. 103 Brazil Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 104 Argentina
Fig. 105 Argentina Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 106 Middle East & Africa
Fig. 107 Middle East & Africa Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 108 South Africa
Fig. 109 South Africa Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 110 Saudi Arabia
Fig. 111 Saudi Arabia Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 112 UAE
Fig. 113 UAE Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 114 Kuwait
Fig. 115 Kuwait Radiotheranostics Market Estimates and Forecasts 2021 - 2033
Fig. 116 Market share of key market players - Radiotheranostics Market